Proto Script Pharmaceutical Corp.
PSCR · OTC
12/31/2016 | 12/31/2015 | 5/31/2014 | 5/31/2013 | |
|---|---|---|---|---|
| Revenue | $1 | $1 | $0 | $0 |
| % Growth | -10.5% | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $1 | $1 | $0 | $0 |
| % Margin | 71.5% | 78.8% | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1 | $1 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $1 | $0 | $0 |
| Operating Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -37.8% | -16.6% | – | – |
| Other Income/Exp. Net | -$7 | $0 | $0 | $0 |
| Pre-Tax Income | -$7 | -$0 | -$0 | -$0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$7 | -$0 | -$0 | -$0 |
| % Margin | -910.4% | -16.5% | – | – |
| EPS | -0.077 | -0.005 | -0.001 | -0.001 |
| % Growth | -1,493.8% | -269.2% | -18.2% | – |
| EPS Diluted | -0.077 | -0.005 | -0.001 | -0.001 |
| Weighted Avg Shares Out | 94 | 30 | 30 | 30 |
| Weighted Avg Shares Out Dil | 94 | 30 | 30 | 30 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -37.1% | -8% | – | – |